What blood work can reveal about cancer
Some cancers do show up in blood work, but not all of them, and not always in the way you might expect. Blood tests cannot diagnose most cancers on their own. Instead, they can detect substances that suggest cancer may be present, prompt further testing, or monitor cancer that has already been diagnosed.
The substances blood tests look for fall into two categories: tumor markers (proteins or other molecules produced by cancer cells) and blood cell abnormalities (changes in the number or appearance of red cells, white cells, or platelets). A high tumor marker does not mean you have cancer—many benign conditions raise these levels—but an unusual result is a reason to investigate further with imaging or a biopsy.
Some cancers are more likely to show up in blood work than others. Blood cancers like leukemia and lymphoma often appear as abnormal cell counts or immature cells visible under a microscope. Cancers that have spread to the bone marrow may also show changes in blood cell production. Solid tumors—like breast, lung, or colon cancer—are less likely to produce detectable changes in routine blood work, though some do release measurable tumor markers into the bloodstream.
Key Takeaways
- Blood tests can detect tumor markers or abnormal cell counts that suggest cancer, but they cannot diagnose most solid tumors on their own.
- Blood cancers like leukemia and lymphoma are more likely to show up in blood work than cancers in organs like the breast or lungs.
- A high tumor marker or abnormal blood cell count is a signal to pursue imaging tests or a biopsy, not a diagnosis.
- Routine blood work ordered for other reasons sometimes uncovers cancer incidentally, but cancer screening blood tests are only recommended for certain cancers and certain people.
Which cancers are most likely to appear in blood tests
Blood cancers are the most reliably detected in blood work because the cancer cells themselves circulate in the bloodstream. Leukemia produces immature white blood cells (blasts) that a lab technician can see under a microscope. Lymphoma may cause abnormal lymphocyte counts or the appearance of atypical cells. Multiple myeloma produces excess immunoglobulin (a protein) that shows up on blood chemistry panels.
Some solid tumors release measurable tumor markers. Prostate cancer is associated with elevated PSA (prostate-specific antigen). Ovarian cancer may raise CA-125 levels. Liver cancer can elevate alpha-fetoprotein (AFP). Colorectal cancer sometimes raises carcinoembryonic antigen (CEA). However, these markers are not specific to cancer—benign conditions, inflammation, and even pregnancy can raise them—so they are not used to diagnose cancer in people without symptoms.
Cancers that have spread to the bone marrow may cause anemia (low red blood cell count), low platelet counts, or other blood cell abnormalities. A person might discover advanced cancer through blood work ordered for fatigue or easy bruising, even though the original tumor would not have shown up in earlier blood tests.
Why most solid tumors do not show up in routine blood work
A tumor growing in your breast, lung, colon, or pancreas does not necessarily release detectable substances into your bloodstream, especially in early stages. The cancer cells are localized in the organ tissue, not circulating through the blood. Routine blood work—a complete blood count or basic metabolic panel—is designed to measure general health markers like cholesterol, glucose, and kidney function, not to hunt for cancer.
This is why blood tests alone cannot screen for most cancers. Detecting a breast cancer requires mammography. Colorectal cancer requires colonoscopy or stool-based tests. Lung cancer in a high-risk person requires a CT scan. These imaging and tissue-based tests directly visualize or sample the organ where cancer grows. Blood work plays a supporting role—it might show that liver function is abnormal, prompting investigation—but it is not the primary detection tool.
Tumor markers and what they actually mean
A tumor marker is a substance—usually a protein—that cancer cells produce in higher amounts than healthy cells do. Common markers include PSA for prostate cancer, CA-125 for ovarian cancer, CEA for colorectal cancer, and HER2 for breast cancer. If your blood test shows an elevated marker, it does not mean you have cancer. It means your doctor should investigate further.
Elevated tumor markers can result from infection, inflammation, benign tumors, or normal variation. A single high result is less meaningful than a rising trend over time. If you have already been diagnosed with cancer, your doctor may order tumor marker tests periodically to see whether treatment is working or whether cancer is returning. In that context, the marker becomes a useful monitoring tool. In screening—testing asymptomatic people—tumor markers are much less reliable.
Some tumor markers are used in screening only for people at very high risk. PSA screening for prostate cancer, for example, is offered to men with a family history of prostate cancer or men over a certain age, though the test's value remains debated because many elevated PSA results do not indicate cancer. Most tumor markers are not recommended for screening the general population.
When blood work uncovers cancer incidentally
Sometimes cancer is discovered by accident. A person goes to their doctor for fatigue and routine blood work reveals a very low red blood cell count (anemia) and abnormal white blood cells. Further testing shows leukemia. Another person has blood work for a physical exam and the results show elevated liver enzymes; imaging then finds liver cancer. These discoveries happen because the cancer has caused measurable changes in blood chemistry or cell counts, not because the blood test was designed to find cancer.
Incidental findings are more common with blood cancers and cancers that have advanced to the point where they affect bone marrow or organ function. They are less common with early-stage solid tumors confined to one organ. This is why people at risk for certain cancers are offered specific screening tests—mammography for breast cancer, colonoscopy for colorectal cancer—rather than relying on blood work to catch them early.
What happens after an abnormal blood test result
If your blood work shows an abnormal result that might suggest cancer—an elevated tumor marker, abnormal cell counts, or unexplained anemia—your doctor will not diagnose cancer based on that result alone. Instead, they will order additional tests. These might include imaging (ultrasound, CT scan, or MRI), a biopsy (removing a tissue sample for microscopic examination), or more specialized blood tests.
The biopsy is the gold standard for cancer diagnosis. A pathologist examines the tissue under a microscope and can identify cancer cells, determine what type of cancer it is, and assess how aggressive it appears. Blood work supports this process—it can raise suspicion and guide which tests to order next—but tissue diagnosis is what confirms cancer.
Blood tests used in cancer screening and monitoring
Screening blood tests for cancer are limited and recommended only in specific situations. PSA testing for prostate cancer is offered to men at risk, though organizations disagree on whether the benefits outweigh the risks of false positives and unnecessary biopsies. Hepatitis B and C screening (blood tests) can identify people at risk for liver cancer, allowing for surveillance with ultrasound. HPV testing (which can be done on blood, though cervical swabs are more common) identifies risk for cervical cancer.
Once cancer is diagnosed, blood tests become more useful. Tumor marker levels may be measured before treatment to establish a baseline, then tracked during and after treatment to see whether the cancer is responding. Complete blood counts monitor whether chemotherapy is affecting bone marrow. Liver and kidney function tests ensure organs are tolerating treatment. In this context, blood work is a standard part of cancer care, even though it was not the tool that found the cancer in the first place.
Frequently Asked Questions
Can a normal blood test mean I definitely do not have cancer?
No. A normal blood test does not rule out cancer, especially early-stage solid tumors. Most cancers in organs like the breast, lung, or colon do not produce detectable changes in routine blood work. If you have symptoms or risk factors for a specific cancer, you need the appropriate screening test for that cancer—not a blood test.
What does it mean if my tumor marker is slightly elevated?
A slightly elevated tumor marker is not a diagnosis. Many benign conditions raise these levels. Your doctor will consider your symptoms, medical history, and other test results to decide whether further investigation is needed. A single elevated result is less concerning than a rising trend over time.
If blood work shows abnormal white blood cells, do I have leukemia?
Abnormal white blood cells in blood work warrant further testing, but they do not automatically mean leukemia. Infection, inflammation, and other conditions can cause abnormal cells to appear. A hematologist (blood specialist) will examine the cells more closely and may order additional tests like a bone marrow biopsy to determine the cause.
Why do doctors order blood work if it cannot diagnose most cancers?
Blood work provides useful information even when it cannot diagnose cancer directly. It can reveal anemia, organ dysfunction, or abnormal cell counts that prompt investigation. It also monitors how a person is tolerating cancer treatment and whether tumor markers are rising or falling after diagnosis.
Should I ask my doctor for a tumor marker blood test for cancer screening?
Tumor marker screening is not recommended for asymptomatic people in the general population because false positives lead to unnecessary testing and anxiety. If you have symptoms or a family history of a specific cancer, talk with your doctor about whether screening tests—imaging or tissue-based tests, not blood tests—are appropriate for you.